Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 691-695

  Benko, Amy S ^a   Cappelletty, Diane M ^a,b   Kruse, James A ^a   Rybak, Michael J ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b DETROIT RECEIVING HOSPITAL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG INTERMITTENT THERAPY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL;

EID: 0030067765     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.691     Document Type: Article

References (36)

1. Bakker-Woudenberg, I. A. M. J., J. C. van den Berg, P. Fontijne, and M. F. Michel. 1984. Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur. J. Clin. Microbiol. 3:131-135.
2. Barriere, S. L., E. Ely, J. E. Kapusnik, and J. G. Gambertoglio. 1985 Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve. J Antimicrob. Chemother. 16:49-59.
3. Bodey, G. P., S. J. Ketchel, and V. Rodriguez. 1979 A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am. J. Med 67:608-618.
4. Bundtzen, R. W., A. U. Gerber, D. L. Cohn, and W. A. Craig. 1989. Postantibiotic suppression of bacterial growth Rev. Infect Dis. 159:281-292.
5. Bustamante, C. I., G. L. Drusano, B. A. Tatem, and H. C. Standiford. 1984 Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother 26:678-682.
6. Cappelletty, D. M., S. L. Kang, S. M. Palmer, and M. J. Rybak. 1995 Pharmacodynamics of ceftazidime administered as intermittent bolus or constant infusion alone and in combination with single-daily-dose amikacin against Pseudomonas aeruginosa ATCC 27853 in an in vitro infection model. Antimicrob. Agents Chemother. 39:1797-1801.
7. Cars, O., and W. A. Craig. 1990. General discussion on antibiotic dosing Scand. J. Infect. Dis. Suppl. 74:282-283.
8. Castela, N., A. M. Taburet, J. Carlet, G. Nitenberg, M. Wolff, J. P. Sollet, J. J. Lefevre, and E. Singlas. 1994. Pharmacokinetics of ceftazidime during continuous infusion in intensive care patients, abstr. 11, p. 16 In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C
9. Cockroft, D. W., and H. M. Gault. 1976. Prediction of creatinine clearance from serum creatinine Nephron 16:31-41
10. Craig, W. A., and S. C. Ebert. 1990. Killing and regrowth of bacteria in vitro, a review Scand J Infect. Dis. Suppl. 74:63-70
11. Craig, W. A., and S. C. Ebert. 1992 Continuous infusion of β-lactam antibiotics. Antimicrob. Agents Chemother 36:2577-2583.
12. Daenen, S., and H. de Vries-Hospers. 1988 Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime Lancet i:937. (Case report.)
13. David, T. J., and J. Devlin. 1989 Continuous infusion of ceftazidime in cystic fibrosis. Lancet i:1454. (Case report.)
14. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections Antimicrob. Agents Chemother. 32:289-297.
15. Gibaldi, M., and D. Perrier. 1982. Noncompartmental analysis based on statistical moment theory, p. 409-417 In J. Swarbrick (ed.), Pharmacokinetics, 2nd ed. Marcel Dekker, Inc, New York
16. Hatano, K., Y. Wakai, Y. Watanaba, and Y. Mine. 1994. Simulation of human plasma levels of β-lactams in mice by multiple dosing and the relationship between the therapeutic efficacy and pharmacodynamic parameters. Chemotherapy 40:1-7.
17. Kuzemko, J., and C. Crawford. 1989 Continuous infusion of ceftazidime in cystic fibrosis. Lancet ii:385. (Case report.)
18. Lagast, H., F. Meunier-Carpentier, and J. Klastersky. 1983. Treatment of gram-negative bacillary septicemia with cefoperazone. Eur. J. Clin. Microbiol. 2:554-558.
19. Lavoic, G. Y., and M. G. Bergeron. 1985. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae Antimicrob. Agents Chemother. 28:404-412.
20. LeBel, M., G. Barbeau, F. Valle, and M. G. Bergeron. 1985. Pharmacokinetics of ceftazidime in elderly volunteers. Antimicrob. Agents Chemother 28:713-715.
21. Leggett. J. E., B. Fantin, S. Ebert, K. Totsuka, B. Vogelman, W. Calame, H. Mattie, and W. A. Craig. 1989. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models. J Infect. Dis. 159:281-292.
22. McGrath, B. J., M. J. Rybak, S. L. Kang, M. J. Ruffing, S. A. Lerner, and M. T. Mutangadura. 1995. A double-blind comparison of once-daily dosing of aminoglycosides versus twice-daily dosing, abstr. A114. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D C.
23. Mouton, J. W., and J. G. den Hollander. 1994. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model. Antimicrob. Agents Chemother. 38:931-936.
24. Mouton, J. W., A. M. Horrevorts, P. G. Mulder, E. P. Prens, and M. F. Michel. 1990. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob. Agents Chemother 34:2307-2311.
25. National Committee for Clinical Laboratory Standards. 1990. Approved standard. Methods for dilution and antimicrobial susceptibility tests for bacteria that grow aerobically National Committee for Clinical Laboratory Standards, Villanova, Pa.
26. National Committee for Clinical Laboratory Standards. 1992. Approved standard. Methodology for the serum bactericidal test; tentative guidelines. National Committee for Clinical Laboratory Standards, Villanova, Pa.
27. Nicolau, D. P., C. H. Nightingale. M. A. Banevicius, Q. Fu, and R. Quintiliani. 1996. Ceftazidime serum bactericidal activity, continuous infusion versus intermittent injections. Antimicrob Agents Chemother. 40:61-64.
28. Rocci, M. L., Jr., and W. J. Jusko. 1983 LAGRAN program for area and moments in pharmacokinetic analysis Comput. Programs Biomed. 16:203-216
29. Roosendaal, R., I. A. J. M. Bakker-Woudenberg, J. C. van den Berg, and M. F. Michel. 1985. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats. J. Infect Dis. 152:373-378.
30. Roosendaal, R., I. A. J. M. Bakker-Woudenberg, M. van den Burghe-van Raffe, and M. F. Michel. 1986. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats Antimicrob. Agents Chemother. 30:403-408.
31. Smith, I. L., and J. J. Schentag. 1984. Noncompartmental determination of the steady-state volume of distribution during multiple dosing J. Pharm. Sci. 73:281-282.
32. Thauvin, C., G. M. Eliopoulos, S. Willey, C. Wennersten, and R. C. Moellering. 1987. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats. Antimicrob Agents Chemother. 31:139-143.
33. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model J Infect Dis. 158:831-847.
34. Winter, M. E. 1994. Elimination rate constant and half-life, p. 41. In M. A. Koda-Kimble and L Y Young (ed.), Basic clinical pharmacokinetics. Applied Therapeutics, Inc., Vancouver, Wash.
35. Winter, M. E. 1994. Creatinine clearance, p. 103. In M. A. Koda-Kimble and L. Y Young (ed.), Basic clinical pharmacokinetics Applied Therapeutics, Inc., Vancouver, Wash.
36. Xiong, Y. Q., G. Potel, J. Caillon, D. Bugnon, P. H. Le Conte, D. Baron, and H. B. Drugeon. 1994. Determination of the in vivo efficacious serum concentration of ceftazidime administered as a continuous IV infusion on an experimental model of P. aeruginosa rabbit endocarditis, abstr. 88, p. 188 In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D C.